GGrantIndex
← Leaderboards

Natasha Kirienko

Rice University

$4,948,787
Attributed
$4,948,787
Total exposure
6
Grants
6
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $1.3M · FY201225
$2M$1.5M$1M$500K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$4,948,787 · 6

By mechanism

R35$3,127,198 · 1
R21$1,390,475 · 3
K22$268,004 · 1
F32$163,110 · 1

Top collaborators

No co-investigators on record.

Others in their field

Top investigators on “Genetic

Research focus

GeneticPathway InteractionsBiologicalCellsSignal TransductionMediatingResponseMitochondriaStressHomeostasisResistanceBiological Adaptation To StressPlayInterestGene ExpressionMalignant NeoplasmsBiochemicalProteinsDefectBindingMetabolicNucleotidesMetabolic DiseasesAging

Grant awards (23)

Regulation of mitochondrial surveillance$457,319
R35 · FY2025 · GM · contact PI
Targeting Multidrug-Resistant Pseudomonas aeruginosa with R Pyocins$439,896
R21 · FY2025 · AI · contact PI
Cheminformatics-based identification of leukemia-targeting molecules$188,600
R21 · FY2025 · CA · contact PI
Molecular mechanisms for clinical dominance of P. aeruginosa ST111 isolates$187,260
R21 · FY2025 · AI · contact PI
Cheminformatics-based identification of leukemia-targeting molecules$74,674
R21 · FY2025 · CA · contact PI
Regulation of mitochondrial surveillance$475,319
R35 · FY2024 · GM · contact PI
Cheminformatics-based identification of leukemia-targeting molecules$227,612
R21 · FY2024 · CA · contact PI
Molecular mechanisms for clinical dominance of P. aeruginosa ST111 isolates$226,502
R21 · FY2024 · AI · contact PI
Administrative Supplements for Equipment Purchases for R35GM129294 Regulation of mitochondrial surveillance$125,829
R35 · FY2024 · GM · contact PI
Diversity Supplement: Cheminformatics-based identification of leukemia-targeting molecules$45,931
R21 · FY2024 · CA · contact PI
Coordinated Regulation of Mitochondrial Surveillance$384,615
R35 · FY2022 · GM · contact PI
Coordinated Regulation of Mitochondrial Surveillance$384,615
R35 · FY2021 · GM · contact PI
Coordinated Regulation of Mitochondrial Surveillance$56,404
R35 · FY2021 · GM · contact PI
Coordinated Regulation of Mitochondrial Surveillance$10,285
R35 · FY2021 · GM · contact PI
Coordinated Regulation of Mitochondrial Surveillance$452,301
R35 · FY2020 · GM · contact PI
Coordinated Regulation of Mitochondrial Surveillance$11,281
R35 · FY2020 · GM · contact PI
Coordinated Regulation of Mitochondrial Surveillance$384,615
R35 · FY2019 · GM · contact PI
Coordinated Regulation of Mitochondrial Surveillance$384,615
R35 · FY2018 · GM · contact PI
Mechanisms of Stimulating Innate Immunity$108,000
K22 · FY2016 · AI · contact PI
Mechanisms of Stimulating Innate Immunity$160,004
K22 · FY2015 · AI · contact PI
Utilizing a novel liquid-killing assay to gain insight into C. elegans immunity$56,978
F32 · FY2014 · AI · contact PI
Utilizing a novel liquid-killing assay to gain insight into C. elegans immunity$53,942
F32 · FY2013 · AI · contact PI
Utilizing a novel liquid-killing assay to gain insight into C. elegans immunity$52,190
F32 · FY2012 · AI · contact PI